What's better than momentum? Mo' momentum.
Let's take a closer look at five of this past week's biggest scorchers.
|
Company |
Sep. 21 | Weekly Gain | My Watchlist |
|---|---|---|---|
|
IRIS International |
$19.47 | 45% | Add |
|
Acadia Pharmaceuticals |
$2.62 | 24% | Add |
|
NII Holdings |
$8.34 | 24% | Add |
|
Complete Genomics |
$3.09 | 16% | Add |
|
Nanosphere |
$3.79 | 15% | Add |
Source: Barron's.
IRIS soared last week after receiving a buyout offer. Shareholders of the medical diagnostics provider will be cashed out at $19.50 a share in a tender offer.
Acadia Pharmaceuticals had a strong midweek run. Top-line results for the critical phase 3 study of a promising drug to treat Parkinson's-related psychosis are expected by the end of November. Expect plenty of volatile trading in the coming weeks as the company reaches that important revelation.
NII Holdings made a winning connection after CEO Steve Dussek increased his stake in the company, by 12%. It's a strong show of confidence for the Latin American wireless service provider.
Complete Genomics notched most of last week's gains on Monday, after the gene-sequencing specialist revealed that it would be acquired by China's BGI-Shenzhen. Complete Genomics had put itself up for sale when it initiated a strategic review earlier this year.
Nanosphere gained ground after the TheStreet.com published a bullish article on the provider of advanced molecular diagnostics systems. The shares also got a continued boost on Friday morning after announcing that its CFO would be speaking at an investor conference.
More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers there's a special report on three hidden winners in a booming industry. The report is free -- like this article -- but it won't be around forever, so check it out now.
